pre formulation stability studies
Post on 07-Apr-2018
223 Views
Preview:
TRANSCRIPT
8/3/2019 Pre Formulation Stability Studies
http://slidepdf.com/reader/full/pre-formulation-stability-studies 1/33
PREFORMULATION STABILITY STUDIES
PRESENTED BY
KADRI MOHAMMED PAYAM
DEPT OF PHARMACEUTICS
1st M.MPHARM
8/3/2019 Pre Formulation Stability Studies
http://slidepdf.com/reader/full/pre-formulation-stability-studies 2/33
INTRODUCTION
Stability is defined as the extent to which the drug
substance retains within the specified limits throughout
its storage period.
Preformulation stability studies are usually assessment of
chemical stability of a new drug.
These studies are conducted under condition typical for
the handling, formulation, storage and administration of
the drug candidate.
8/3/2019 Pre Formulation Stability Studies
http://slidepdf.com/reader/full/pre-formulation-stability-studies 3/33
PURPOSE To develop a stable dosage form
To establish expiry date
To study drug decomposition kinetics and to know more
about the degraded products
To collect the long term(12months) , intermediate(12months) and accelerated stability data (6 months)
To have an idea of what excipients to use, and how bestto put them together with drug.
To know that no toxic substance are formed
8/3/2019 Pre Formulation Stability Studies
http://slidepdf.com/reader/full/pre-formulation-stability-studies 4/33
Consequently, the preformulation scientist must try todefine those study designs and condition that show the
greatest probability of success.
Therefore, the objective of preformulation stabilityprogram is to identify and help to avoid or control
situation where the stability of the active ingredient may
be compromised.
For drug substance to be developed in to tablet dosage
form, this objective may be achieved by investigating the
stability of the drug under the following three categories
8/3/2019 Pre Formulation Stability Studies
http://slidepdf.com/reader/full/pre-formulation-stability-studies 5/33
1. Solid state stability of the drug
2. Compatibility studies (stability in the presence of
excipients )
3. Solution phase stability.( including stability in
gastrointestinal fluids and granulating solvents)
8/3/2019 Pre Formulation Stability Studies
http://slidepdf.com/reader/full/pre-formulation-stability-studies 6/33
SOLUTION STABILITY
The primary objective of this phase of preformulationresarch is to identify conditions necessary to form astable solution. This includes effects of pH, ionicstrength, co-solvent, light, temperature and oxygen on
solution.
In this experiments are carried out at the extremes of
temp and pH (0.1N HCL and 0.1N NaOH at 90
0
C )andthe degraded samples are used to confirm assayspecificity and provide estimates for maximum rates of degradation.
8/3/2019 Pre Formulation Stability Studies
http://slidepdf.com/reader/full/pre-formulation-stability-studies 7/33
This intial expriment should be followed by the generation
of a complete pH-rate profile to identify the pH of maximum stability.
Aqueous buffer are used to produce solutions over wide
range of pH values with constant level of drug, cosolventand ionic strength.
Since most solution pharmaceuticals are intended forparental routes of admistration.
For parenteral route – pH studies are conducted at aconstant ionic strength that is compactable with thephysiological medium.
8/3/2019 Pre Formulation Stability Studies
http://slidepdf.com/reader/full/pre-formulation-stability-studies 8/33
Ionic strength for any new buffer solution may becalculated from the following equation.
Ionic strength () = ½ m1z1
2
Where,
m1 – molar concentration of the ion,
z1 – valency,
In the solution, stability studies are carried out for :
1. Cosolvents
2. pH profile rate
8/3/2019 Pre Formulation Stability Studies
http://slidepdf.com/reader/full/pre-formulation-stability-studies 9/33
COSOLVENTS
Cosolvents may be needed to achieve drugconcentration that are necessary for analytic sensitivity,or to produce a defined initial condition.
Stability solutions produced are placed in flint glassampoules(sealed) and stored at constant temperatures.
Some of the ampoules may be stored at variety of temperatures to provide data for calculating activationenergies.
8/3/2019 Pre Formulation Stability Studies
http://slidepdf.com/reader/full/pre-formulation-stability-studies 10/33
Light sensitive sample solution samples may be stored in
amber and yellow green glass container.
Potential for oxidation is intially unknown, some of thesolution samples should also be subjected to further testing
1. With an excessive headspace of oxygen,
2. With a headspace of an inert gas such as helium or
nitrogen,3. With inorganic antioxydant such as sodium
metabisulphate,
4. With organic antioxydent such as butylated hydroxy
toluene-BHT.
8/3/2019 Pre Formulation Stability Studies
http://slidepdf.com/reader/full/pre-formulation-stability-studies 11/33
pH RATE PROFILE
Stability data generated at each pH and temp are analyzedkinetically to yield apparent decay rate constant (k) .
Arrhenius plot is constructed by plotting log k Vs
reciprocal of absolute temp at which each particular buffersolution was stored during stability test.
Shelf life can be obtained from appropriate kinetic
equationsEg : for 1st order decay process
t10% = -ln 0.90/k 1 = 0.105/k 1
Where t10% is the time for 10% decay
8/3/2019 Pre Formulation Stability Studies
http://slidepdf.com/reader/full/pre-formulation-stability-studies 12/33
Solutions undergo accelerated decompositions uponaddition of acids or bases.
These are catalysed by hydrogen or hydroxyl ions.Ex:
pH profile rate of acid base catalysed hydrolysis of methyl-o-phenyl-2-piperidylacetate.Here at pH 1-3
there is a decrease in rate due to hydrogen ion catalysis.At pH 3-7 there is increase in rate due to hydroxyl ioncatalyst.
8/3/2019 Pre Formulation Stability Studies
http://slidepdf.com/reader/full/pre-formulation-stability-studies 13/33
SOLID STATE STABILITY
Objective is to find out a stable storage conditions and
identification of compactable excepients for formulation
Solid state stability refers to physical as well as chemical
stability.
Pharmaceutical solid degrade as a result of solvolysis,
oxidation, photolysis and pyrolysis.
The mechanisms of solid state degradation are complex
and difficult to elucidate.
8/3/2019 Pre Formulation Stability Studies
http://slidepdf.com/reader/full/pre-formulation-stability-studies 14/33
The common factors that cause solid state reactions are
heat, light, oxygen and moisture.
Various approaches for solid state state stability include:
1. Elevated temperature studies
2. Stability under high humidity conditions
3. Stability to oxidation,hydrolysis4. Photolytic stability
8/3/2019 Pre Formulation Stability Studies
http://slidepdf.com/reader/full/pre-formulation-stability-studies 15/33
ELEVATED TEMPERATURE STUDIES
These samples are stored at higher temperatures and
should be examined for physical and chemical changes
at frequent intervals and any change, when compared to
an apropriate , should be noted.
Substantial changes is seen,samples stored at lower
temperatures are examined.
If no changes seen after 30 days at 600c, the stability is
excellent.
8/3/2019 Pre Formulation Stability Studies
http://slidepdf.com/reader/full/pre-formulation-stability-studies 16/33
This data obtained is extrapolated using the Arrheniustreatment to determine rate of degradation at lowtemperatures.
Here logarithm of rate constant is plotted against reciprocal
of absolute temperature.
The plot is extrapolated to obtain the rate constant.
Example: Ergot alkaloids degrade completely within a year when
stored above 45°C and the rate is less than 1% per yearbelow 35°C.
8/3/2019 Pre Formulation Stability Studies
http://slidepdf.com/reader/full/pre-formulation-stability-studies 17/33
8/3/2019 Pre Formulation Stability Studies
http://slidepdf.com/reader/full/pre-formulation-stability-studies 18/33
If humidity affects drug stability, then stability data obtainedat various humidity's may be linearised with respect tomoisture by:-
KH = [gpl].K0
Where [gpl] is the concentration of water in atmosphere ingrams per liter.
K0 is the decay rate constant at zero relativehumidity.
8/3/2019 Pre Formulation Stability Studies
http://slidepdf.com/reader/full/pre-formulation-stability-studies 19/33
STABILITY TO HYDROLYSIS The most likely causes of drug instability is hydrolysis.
Drugs, which are susceptible to hydrolysis are: Penicillin's,Cephalosporin's, Aspirin, Chlormphenicol, Esters, Lactamsand Amides.
ExamplesCLASS EXAMPLE
Ester Aspirin
Amide ChloramphenecolLactum Methicillin
Lactone Spironolactone
Sulphonamide Sulphapyrazine
8/3/2019 Pre Formulation Stability Studies
http://slidepdf.com/reader/full/pre-formulation-stability-studies 20/33
The use of anhydrous vegetable oils, reduce the chance of
hydrolytic decomposition
Decomposition can be prevented in solution forms by suspending
in non-aqueous vehicle rather than dissolving by them in aqueous
solvent
Storage under refrigeration is advisable for most preparations
considered unstable due to hydrolysis
For hydrolysable drug the pH of optimum stability is between pH
5 and 6
8/3/2019 Pre Formulation Stability Studies
http://slidepdf.com/reader/full/pre-formulation-stability-studies 21/33
STABILITY TO OXIDATION
This test must be evaluate to establish if the final productshould be packaged under inert atmospheric condition and if should contain an antioxident.
Oxidative reactions are influenced by light and metal ions.
Auto-oxidation is a common form of oxidative degradationwhich involves free radical mechanism.
Antioxidants are used to overcome this problem some of them are sodium sulphite,ascorbic acid,butylhydroxyanisole.
8/3/2019 Pre Formulation Stability Studies
http://slidepdf.com/reader/full/pre-formulation-stability-studies 22/33
Samples are stored in large 25 ml vials for injection, capped with
Teflon lined rubber stopper and the head space flooded with dry
oxygen.
To confirm that the decay is caused by oxidation only and not due
to reduced humidity another set of vials flooded with dry
atmospheric nitrogen is used.
These samples are than analyzed for chemical stability,
polymorphic changes and discoloration
8/3/2019 Pre Formulation Stability Studies
http://slidepdf.com/reader/full/pre-formulation-stability-studies 23/33
PHOTOLYTIC STABILITY
Many drug substance fade or darken on exposure to light.
It can be readily controlled by using amber glass or opaque
container or by using dye to mask the discoloration.
Drugs that are prone to photolysis reaction are ascorbic
acid,sulphonamide,steroids.
Flint glass absorbs at 80% in 290-320nm and amber glass absorbs
more than 95%.
8/3/2019 Pre Formulation Stability Studies
http://slidepdf.com/reader/full/pre-formulation-stability-studies 24/33
DETERMINATION OF SOLID STATESTABILITY OF A NEW DRUG
The weighed samples are place in open screw capped vials and areexposed directly to various temperatures, humidity's and lightintensities for up to 12 weeks .
Samples usually consist of three 5-10 mg weighed samples at eachdata point for HPLC analysis and approximately 10-50 mg of sample for polymorph evaluation by differential scanningcalorimetry of IR
All these can be overcome by following ways:
The stability of Penicillins can be increased by reducing itssolubility, by using additives like citrates, dextrose, sorbitol etc.
8/3/2019 Pre Formulation Stability Studies
http://slidepdf.com/reader/full/pre-formulation-stability-studies 25/33
Drugs, which are susceptible to acid base catalyzed hydrolysis,
can be stabilized by determining the pH of maximum stability and
by formulating the product at that pH.
By using insoluble salt form of a solid dosage form or preparation
of oral liquid dosage form by replacement of water by some other
non aqueous solvents such as polyhydroxy alcohols.
Eg: Acetaminophen solution contains high proportion of
sorbitol and propylene glycol.
8/3/2019 Pre Formulation Stability Studies
http://slidepdf.com/reader/full/pre-formulation-stability-studies 26/33
COMPATIBILITY STUDIES
Stability in presence of excipients.
A typical tablet contain binders, disintegrants, lubricants, and
diluents.
In tablet compatibility of drug and excipient will depend on the
nature of the excipient, and size and the potency of the tablet
For eg:- Compound with bulk instability at high humidity should
be formulated with anhydrous excipients.
Similarly , pH of maximum stability should match with pH of
aqueou solution of the drug and excipient.
8/3/2019 Pre Formulation Stability Studies
http://slidepdf.com/reader/full/pre-formulation-stability-studies 27/33
The three techniques commonly employed in drug - excipient
compatibility screening are
1. Chromatographic techniques using either HPLC or TLC
2. Differential thermal analysis
3. Diffuse reflectance spectroscopy
8/3/2019 Pre Formulation Stability Studies
http://slidepdf.com/reader/full/pre-formulation-stability-studies 28/33
CHROMATOGRAPHIC TECHNIQUES
Drug and excipients mixture are granulated with water and
solvented at elivated temperature.
Granulation is carried out so that mixture contain fixed amount of
moisture at elevated temperatures.
The samples are examined periodically for appearance and
analyzed for any decomposition using HPLC and TLC.
8/3/2019 Pre Formulation Stability Studies
http://slidepdf.com/reader/full/pre-formulation-stability-studies 29/33
DIFFERENTIAL THERMAL ANALYSIS
In this 5mg of drug is taken in a 50% mixture with excipient.
It should be observed in presence of nitrogen to avoid oxidative
and pyrrolytic effects at a standard heating rate on DSC apparatus.
8/3/2019 Pre Formulation Stability Studies
http://slidepdf.com/reader/full/pre-formulation-stability-studies 30/33
Drug
50% Mixture
Excipient
DSC
NoInteraction
Interaction
TLC
SignificantBreakdown?
YesAlternateExcipients
No
Recommend
Excipients
8/3/2019 Pre Formulation Stability Studies
http://slidepdf.com/reader/full/pre-formulation-stability-studies 31/33
DIFFUSE REFLECTANCE SPECTROSCOPY
Detect and monitor drug excipient interaction.
Exposed to incident radiation
Partly absorbed and partly refelected in a diffuse manner.
Diffuse reflectance spectroscopy is used to investigate physical
chemical changes occurring on a solid surfaces.
A shift in the diffuse reflectance spectrum of the drug due to the
presence of the excipients indicates physical absorption where as
the appearnce of new peak indicates formation of degradation
product.
8/3/2019 Pre Formulation Stability Studies
http://slidepdf.com/reader/full/pre-formulation-stability-studies 32/33
REFERENCES :
1. Lachman L, Liebermann HA, Kanig JL. The theory and practiceof industrial pharmacy. 3rd edition. Bombay, Varghese publishinghouse;1991P.
2. Liebermann HA, Lachman L, Schwartz JB. Pharmaceutical
dosage forms:Tablets vol one. 2
nd
ed. New york.Basel: MarcelDekker,Inc;2005.p. 43-7
3. Banker S.G. and Rhodes T.C., Modern p. Modern Parmaceutics4th Edn, Marcel Dekker, Inc. New York, Vol. 121, p.178-82
4. http://books.google.co.in/books?id=RQJq3aosg34C&pg=PA4&lpg=PA4&dq=example+for+a+drug+undergone+preformulation+stablity+studies&source=bl&ots=R1FgUB1Cpl&sig=b7U_XVX6IfObgtKSWpUZaChTn5c&hl=en&ei=LaJ_SreuMMqAkQXo-9mGAw&sa=X&oi=book_result&ct=result&resnum=7#v=onepage&q=&f=false[cited on 2009 aug10]
8/3/2019 Pre Formulation Stability Studies
http://slidepdf.com/reader/full/pre-formulation-stability-studies 33/33
THANK
U
top related